量子分子共振通过抑制IL36G和SPRR2BB来改善亚托皮炎
Jinyoung Kim, Barsha Deshar, Min Hwang
1Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea; Department of Medical Sciences, Graduate School, The Catholic University of Korea, Seoul 06591, Korea; Institute for Aging and Metabolic Diseases, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
BMB reports
|January 5, 2025
概括
量子分子共振 (QMR) 提供了一种新的,非侵入性治疗阿托皮性皮炎 (AD). 这种电磁疗法在小鼠模型中有效降低了皮肤病变和炎症,准了参与AD病变发生的关键基因.
科学领域:
- 皮肤病学 皮肤病学
- 生物物理学的生物物理.
- 分子生物学分子生物学
背景情况:
- 亚托皮炎 (AD) 是一种慢性炎症性皮肤疾病,因皮质类固醇治疗而暂时缓解症状.
- 目前对阿尔茨海默病的治疗方法无法治愈,因此需要新的治疗策略.
- 量子分子共振 (QMR) 是一种基于电磁场的非侵入性方法,作为一种潜在的替代疗法.
研究的目的:
- 调查量子分子共振 (QMR) 作为亚托皮性皮炎 (AD) 的新疗法策略的疗效.
- 在小鼠模型中评估QMR对AD类皮肤病变,细胞透和表皮完整性的影响.
- 确定QMR的分子标,包括参与AD炎症和超色症的特定基因.
主要方法:
- 使用丁二二 (DNCB) 诱导了一种亚托皮性皮肤炎小鼠模型.
- 在DNCB诱导的AD小鼠中,用德甲 (DXM) 或QMR治疗.
- 分析了皮肤病变,巨细胞和巨细胞的透,表皮厚度和基因表达 (转录组分析).
- 在人类角质细胞上进行了RNA沉默,以验证基因标.
主要成果:
- 在DNCB诱导的小鼠模型中,QMR显著改善了AD类皮肤病变.
- QMR减少了巨细胞和巨细胞的透,表皮厚化,并恢复了底层膜的完整性.
- 转录组分析发现IL36G和SPRR2B是DNCB调节和QMR反调节的关键基因.
- QMR治疗导致小鼠皮肤IL36G和SPRR2B表达的显著减少.
结论:
- 量子分子共振 (QMR) 在改善亚托皮性皮肤炎方面显示出有前途的治疗作用.
- QMR有效地降低了与AD相关的炎症和超化症.
- QMR的治疗效果至少部分通过向IL36G和SPRR2B基因表达来调节.
相关概念视频
T Cell Types and Functions
613
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
613
Inflammatory Response
1.5K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.5K
Allergic Reactions
27.1K
Overview
27.1K
Drugs Used in Lower Respiratory Disorders: Overview
241
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
241
The JAK-STAT Signaling Pathway
8.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.3K


